QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is SLU-PP-332?
SLU-PP-332 is a potent synthetic agonist of estrogen-related receptors ERRα and ERRγ — orphan nuclear receptors that regulate mitochondrial biogenesis, fatty acid oxidation, and energy metabolism. Activates PGC-1α-dependent transcriptional programs mimicking the gene expression signature of endurance exercise. Research tool for mitochondrial biology, metabolic disease, and exercise mimetic pharmacology. Research use only.
Research Applications
ERRα/ERRγ Agonism
Nuclear receptor activation, target gene transcription, PGC-1α coactivation
Mitochondrial Biogenesis
TFAM, NRF1/2 upregulation, mtDNA copy number, oxidative capacity
Fatty Acid Oxidation
CPT1, ACADM, HADHA expression — β-oxidation flux studies
Exercise Mimetic Research
Endurance gene signature without physical training — metabolic adaptation models
Metabolic Disease Models
Obesity, insulin resistance, skeletal muscle oxidative capacity restoration
Quick Specs
| Form | Tablet — 500mcg per tablet, 100-tablet bottle |
| CAS Number | 2411025-13-3 |
| Molecular Formula | C₂₄H₂₃N₃O₃ |
| Molecular Weight | 405.5 g/mol |
| Compound Type | ERRα/ERRγ Nuclear Receptor Agonist |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |
